Diffuse lamellar keratitis
Diffuse Lamellar Keratitis
Diffuse Lamellar Keratitis (DLK) is a non-infectious inflammatory condition that can occur after laser-assisted in situ keratomileusis (LASIK) surgery. It is characterized by the presence of white blood cells beneath the corneal flap created during the procedure.
History[edit | edit source]
DLK was first described in the late 1990s as a complication following LASIK surgery. It was initially referred to as "Sands of the Sahara" due to its appearance under the microscope.
Causes[edit | edit source]
The exact cause of DLK is not fully understood, but it is believed to be related to surgical trauma, the presence of foreign substances, or an immune response. Factors such as microkeratome use, laser energy, and environmental contaminants have been implicated.
Symptoms[edit | edit source]
Patients with DLK may experience:
- Blurred vision
- Light sensitivity
- Redness of the eye
- Discomfort or pain
Diagnosis[edit | edit source]
DLK is diagnosed through a slit-lamp examination, where the characteristic white blood cell infiltrates can be observed beneath the corneal flap. It is important to differentiate DLK from infectious keratitis, which requires different management.
Treatment[edit | edit source]
Treatment of DLK typically involves the use of topical corticosteroids to reduce inflammation. In severe cases, lifting and irrigating the flap may be necessary to remove inflammatory cells. Early detection and treatment are crucial to prevent permanent vision impairment.
Prognosis[edit | edit source]
With prompt treatment, most patients recover fully without long-term effects on vision. However, if left untreated, DLK can lead to scarring and permanent vision loss.
Prevention[edit | edit source]
Preventive measures include meticulous surgical technique, proper sterilization of instruments, and minimizing exposure to potential contaminants during and after surgery.
See also[edit | edit source]
External[edit source]
B[edit source]
C[edit source]
D[edit source]
F[edit source]
G[edit source]
I[edit source]
L[edit source]
M[edit source]
P[edit source]
R[edit source]
S[edit source]
U[edit source]
V[edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD